Samuel Kaplan, PhD, is a biologist specializing in stem cells, genetic engineering, differentiation, and bioinformatics. They are currently a Senior Scientist at Merck, focusing on CHO cell line development and pipeline management. Previously, Samuel held research positions at Rubius Therapeutics and Brigham and Women's Hospital, where they contributed to various projects including cell culture optimization and protein investigations. Samuel is also pursuing a PhD at Weill Cornell Graduate School of Medical Sciences, concentrating on human genetic variation's role in organ development and disease.
This person is not in the org chart
This person is not in any teams
This person is not in any offices